CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-16 | Labrucherie Gil M SVP, COO & CFO | Sale | −17,448 | $3.95 | $69K | 312,905 |
| 2022-05-15 | Labrucherie Gil M SVP, COO & CFO | Grant or award | +28,750 | 330,353 | ||
| 2022-02-16 | Labrucherie Gil M SVP, COO & CFO | Sale | −7,579 | $10.95 | $83K | 301,603 |
| 2021-12-16 | Labrucherie Gil M SVP, COO & CFO | Grant or award | +52,950 | 309,182 | ||
| 2021-12-16 | Labrucherie Gil M SVP, COO & CFO | Grant or award · Stock Option | +94,000 | 94,000 | ||
| 2021-11-18 | Labrucherie Gil M SVP, COO & CFO | Sale | −3,000 | $12.69 | $38K | 256,682 |
| 2021-11-16 | Labrucherie Gil M SVP, COO & CFO | Sale | −21,149 | $13.16 | $278K | 259,682 |
| 2021-11-15 | Labrucherie Gil M SVP, COO & CFO | Grant or award | +40,150 | 280,831 | ||
| 2021-10-12 | Labrucherie Gil M SVP, COO & CFO | Grant or award · Stock Option | +71,550 | 71,550 | ||
| 2021-08-17 | Labrucherie Gil M SVP, COO & CFO | Sale | −3,000 | $13.56 | $41K | 240,231 |
| 2021-08-16 | Labrucherie Gil M SVP, COO & CFO | Sale | −7,867 | $13.83 | $109K | 243,231 |
| 2021-05-17 | Labrucherie Gil M SVP, COO & CFO | Sale | −7,898 | $18.30 | $145K | 251,098 |
| 2021-02-16 | Labrucherie Gil M SVP, COO & CFO | Sale | −7,977 | $22.37 | $178K | 258,996 |
| 2021-02-04 | Labrucherie Gil M SVP, COO & CFO | Option exercise | +50,000 | $8.80 | $440K | 316,973 |
| 2021-02-04 | Labrucherie Gil M SVP, COO & CFO | Sale | −50,000 | $19.81 | $991K | 266,973 |
| 2021-02-04 | Labrucherie Gil M SVP, COO & CFO | Option exercise · Stock Option | −50,000 | 0 | ||
| 2021-02-03 | Labrucherie Gil M SVP, COO & CFO | Option exercise | +25,000 | $8.80 | $220K | 291,973 |
| 2021-02-03 | Labrucherie Gil M SVP, COO & CFO | Option exercise | +25,000 | $8.80 | $220K | 316,973 |
| 2021-02-03 | Labrucherie Gil M SVP, COO & CFO | Sale | −50,000 | $19.61 | $981K | 266,973 |
| 2021-02-03 | Labrucherie Gil M SVP, COO & CFO | Option exercise · Stock Option | −25,000 | 0 |
Page 1 of 5 · 91 trades